THERACLION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.36 EUR | -1.10% |
|
+4.35% | -7.22% |
| Sales 2021 | 1.48M 1.58M 127M | Sales 2022 | 1.24M 1.32M 106M | Capitalization | 26.15M 27.96M 2.24B |
|---|---|---|---|---|---|
| Net income 2021 | -3M -3.21M -257M | Net income 2022 | -4M -4.28M -342M | EV / Sales 2021 | 24.8 x |
| Net Debt 2021 | 6.99M 7.47M 598M | Net Debt 2022 | 6.52M 6.97M 559M | EV / Sales 2022 | 26.4 x |
| P/E ratio 2021 |
-7.93
x | P/E ratio 2022 |
-5.35
x | Employees | 30 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 71.21% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -1.10% | ||
| 1 week | +4.35% | ||
| Current month | -5.26% | ||
| 1 month | -5.76% | ||
| 3 months | -29.96% | ||
| 6 months | -24.21% | ||
| Current year | -7.22% |
1 week
0.35
0.37
1 month
0.340.39
Current year
0.310.68
1 year
0.300.85
3 years
0.302.28
5 years
0.302.76
10 years
0.3014.00
| Managers | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 31/12/19 |
Laurence Géricot
DFI | Director of Finance/CFO | - | - |
Gaylord Tallec
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ari Kellen
BRD | Director/Board Member | - | 12/02/19 |
Renaud Saleur
BRD | Director/Board Member | - | 31/01/18 |
Yann Duchesne
CHM | Chairman | 67 | 23/01/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.36 | -1.10% | 7,377 |
| 25/04/24 | 0.364 | +0.55% | 9,649 |
| 24/04/24 | 0.362 | +0.56% | 13 |
| 23/04/24 | 0.36 | 0.00% | 7,709 |
| 22/04/24 | 0.36 | +4.35% | 1,383 |
Real-time Euronext Paris, April 26, 2024 at 04:35 pm
More quotes
Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows:
- sale of equipment (61.8%);
- sale of consumables (29%);
- provision of after-sales services (9.2%).
Export accounts for 99.7% of net sales.
Calendar
18/09/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.22% | 17.42M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- ALTHE Stock
